TIPE2 Associated With Kidney Transplant

This study has suspended participant recruitment.
Sponsor:
Information provided by:
Xi’an Jiaotong University College of Medicine
ClinicalTrials.gov Identifier:
NCT01059292
First received: January 28, 2010
Last updated: NA
Last verified: October 2009
History: No changes posted
  Purpose

TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. The investigators want to know whether TIPE2 is a risk factor for graft loss and gives rise to the immune dysfunction in renal transplant patients.


Condition
Renal Transplant

Study Type: Observational
Official Title: Department of Renal Transplantation, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China

Resource links provided by NLM:


Further study details as provided by Xi’an Jiaotong University College of Medicine:

Estimated Enrollment: 93
Study Start Date: October 2009
  Eligibility

Ages Eligible for Study:   20 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

kidney transplant patients and healty Volunteers

Criteria

Inclusion Criteria:

  • long-term surival(>5year),AR and CR kidney transplant patients and healty Volunteers as control

Exclusion Criteria:

  • without hepatitis , tumor and infections
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Department of Renal Transplantation, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University
ClinicalTrials.gov Identifier: NCT01059292     History of Changes
Other Study ID Numbers: jia123456
Study First Received: January 28, 2010
Last Updated: January 28, 2010
Health Authority: China: Ethics Committee

Keywords provided by Xi’an Jiaotong University College of Medicine:
we have complieted party research

ClinicalTrials.gov processed this record on April 23, 2014